Personalizing Treatment for Acute Alcoholic Hallucinosis: Clinical Utility of Integrated Pharmacogenetic Testing, Metabolic Phenotyping, and microRNA Biomarkers.

Saved in:

Bibliographic Details
Title:	Personalizing Treatment for Acute Alcoholic Hallucinosis: Clinical Utility of Integrated Pharmacogenetic Testing, Metabolic Phenotyping, and microRNA Biomarkers.
Authors:	Skryabin V; Skryabin, PhD, MD, head of clinical department, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Masyakin A; Masyakin, PhD, MD, director, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Pozdniakov S; Pozdniakov, researcher, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Shatokhin I; Shatokhin, researcher, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Sokolova S; Sokolova, researcher, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Ivanchenko V; Ivanchenko, laboratory research assistant, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Makartseva P; Makartseva, psychiatrist, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.
Source:	Psychopharmacology bulletin [Psychopharmacol Bull] 2026 Jan 02; Vol. 56 (1), pp. 82-91.
Publication Type:	Journal Article; Randomized Controlled Trial
Journal Info:	Publisher: MedWorks Media Country of Publication: United States NLM ID: 0101123 Publication Model: Print Cited Medium: Internet ISSN: 2472-2448 (Electronic) Linking ISSN: 00485764 NLM ISO Abbreviation: Psychopharmacol Bull Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2472-2448
DOI:	10.64719/pb.15425